Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001226801 | SCV001399127 | pathogenic | Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 7; Autosomal recessive limb-girdle muscular dystrophy type 2U | 2019-11-12 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Glu235Valfs*4) in the ISPD gene. It is expected to result in an absent or disrupted protein product. This variant is present in population databases (rs781097746, ExAC 0.002%). This variant has not been reported in the literature in individuals with ISPD-related conditions. Loss-of-function variants in ISPD are known to be pathogenic (PMID: 23288328). For these reasons, this variant has been classified as Pathogenic. |